Strong sides of clinic

Quality & Our strong sides

We do not deny that stem therapy is still referred to as experimental in world medicine, this is mainly due to the lack of a large number of clinical trials, primarily due to the high cost of biomaterial. But this is the only one potential direction of medicine, which gives real results in the treatment of serious diseases and conditions.

We guarantee our patients the purity of the product, safety of use, we guarantee the complete elimination of complications, side effects,  because  we control ourselves all processes from material sampling, cultivation, injections and controlling of the result.

Ukraine was one of the first countries in the world to start research with different types of stem cells since 1985 on science level.

In 1999 Ukrainian Parliament approved Law of Ukraine about the Transplantation of Organs and Other Anatomical Structures to Human that regulates the application of fetal ( umbilical and other types) stem cells in treatment of people in severe disease conditions. From those moment were conducted dozens of preclinical study and clinical trials on the efficacy of  stem cells transplantation .This Law reviews introduction of  stem cells into body as transplantation, and the cells themselves as graft.

1)We are the pioneers in the area of cell therapy using cryopreserved, tissue-specific stem/progenitor cells of origin; more than 37 years

2) We have the largest cell banks in Ukraine and have successfully send our bio materials for patients from all over the world including  Poland, Israel, USA, China, UAE, Turkey, Germany.. etc.; On legal collaboration we work with the biggest clinic: Charite Clinic ( Germany) , Israel Medical Centre Shiba, Clinic of Munich University, Mayo Clinic ( USA)

3)Stem cells banking legislation differs from country to country. For example in the USA umbilical cord blood banks` practice is strictly controlled by FDA (organization that is also involved in medicine and food control). FDA approved using some kinds of stem cell in treatment of some diseases!!! In addition, cord blood banks in New-York, New-Jersey and California require additional accreditation to practice legally. Biobank, that doesn`t have such an accreditation, has no right to function at all. In the EU cord blood banks are coordinated and controlled by international organization.  Net cord supported by European Parliament. Net cord both controls the activities of biobanks, and propagates umbilical cord blood banking among people. Ukrainian legislation requires umbilical cord blood banks to satisfy license conditions developed by The Ministry of Health Care of Ukraine. Subject to this satisfaction, the biobank is granted permission for licensed activities such as cells and tissue preservation.

4)All our technologies are patented and protected by copyrights. Our scientific results are published in national and international journals; Cell Biology and Translational Medicine, MDPI, Oxford press, World journal of Stem Cells, Life Science and others expert publications.

5) Our consultants are the leading experts of Ministry of Health and National Academy of Sciences of Ukraine. We partner with leading Ukrainian Research Institutes;

6) We are the member of the International Society for Cell Therapy (ISCT) , International Placenta Stem Cell Society (IPLASS), International Society for Stem Cell Research (ISSCR), International Federation of Placental Research Associations (IFPA)

7) The international quality management system ISO 9001:2015 constantly allows us to monitor and improve the quality of medical services and technological processes in order to meet maximally the needs of our patients. The leading international certification company TÜV Rheinland / LGA InterCert (Germany) conducted an audit for the compliance of our company

8) we are the company that combine: own  medical center 8000 m2, cryobank is located on more than a 1000 m² of a separated biotechnological complex, including its own clinical diagnostics laboratory, PCR laboratory, processing laboratories, research laboratory, quarantine and main cryopreservation laboratory/facility. In addition, the complex includes a round-the-clock logistics service and information support service, client department, as well as departments providing uninterrupted operation of the complex.

 

The biotechnological complex is equipped with modern equipment, has 24/7 multi-level protection and is capable of operating autonomously for a long time, due to the availability of autonomous systems of life support, generators and additional reserves of liquid nitrogen. Currently, the company employs more than 600 highly qualified staff and attracted specialists.

 Our Clinic and International Network

Our clinic operates at the forefront of regenerative and cellular medicine, with established medical centers in Ukraine and Bulgaria, as well as a specialized advanced laboratory facility in Austria. This international structure allows us to combine clinical expertise, cutting-edge biotechnology, and strict European regulatory oversight within a single integrated system. Patients who work with us benefit not only from personalized treatment protocols but also from the assurance that their therapy is supported by internationally recognized scientific and laboratory standards. Our multidisciplinary team includes regenerative medicine specialists, cell biologists, neurologists, immunologists, and laboratory scientists who collaborate closely to ensure that every therapeutic product and procedure meets the highest level of medical excellence.

The geographic distribution of our facilities is a deliberate strategic choice. Our clinics in Ukraine and Bulgaria focus on patient evaluation, individualized treatment planning, and clinical application of regenerative therapies. Meanwhile, our Austrian laboratory serves as a central hub for research, bioengineering, and the cultivation of highly specialized cellular and exosome-based products. Austria’s strong regulatory environment, rigorous biomedical oversight, and advanced scientific infrastructure enable us to maintain exceptional control over every stage of product development, from cell sourcing to final therapeutic formulation.

---

Uniqueness of Our Cultivated Bioproducts

One of the defining features of our clinic is the uniqueness of our cultivated bio-products, which include advanced stem cell cultures, stem cell-derived exosomes, mitochondrial support formulations, and organ-specific regenerative compounds. Unlike generic cell therapies, our products are developed using proprietary cultivation techniques that optimize cellular viability, functional potency, and therapeutic signaling capacity. We focus not only on cell survival but also on the bioactivity of the molecules they produce — including growth factors, regulatory microRNAs, cytokines, and extracellular vesicles that actively influence tissue repair and rejuvenation.

Our laboratory specializes in the development of highly differentiated and tailored cellular preparations, designed to address specific medical or regenerative needs. This includes targeted formulations aimed at supporting neural repair, immune modulation, skin rejuvenation, metabolic health, liver function, and musculoskeletal recovery. Each bio-product undergoes extensive characterization to ensure that it delivers predictable, reproducible, and biologically meaningful effects rather than acting as a generic or poorly defined cellular mixture.

---

Quality Control, Purity, and International Compliance

Quality and safety are the foundation of our work. Our Austrian laboratory operates under strict Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) standards, which are internationally recognized benchmarks for biomedical and pharmaceutical production. Every batch of cultivated cells, exosomes, or bioactive compounds is subjected to rigorous testing for purity, sterility, genetic stability, and functional activity before being cleared for clinical use. This includes microbial screening, endotoxin testing, viability assessment, and molecular profiling to confirm that the product meets our exact specifications.

In addition to laboratory quality control, our clinical protocols in Ukraine and Bulgaria are aligned with European and international medical guidelines for regenerative medicine and cellular therapies. We adhere to ethical sourcing of biological materials, transparent documentation of processes, and continuous monitoring of patient outcomes. Our commitment to regulatory compliance ensures that our treatments are not only innovative but also responsible, scientifically grounded, and safe for long-term application.

---

Commitment to Innovation and Patient Safety

Ultimately, what sets our clinic apart is the seamless integration of clinical expertise, advanced biotechnology, and uncompromising quality control. We do not view stem cell and exosome therapy as experimental or speculative — we treat it as a precise, evolving medical discipline that requires scientific rigor, technological sophistication, and ethical responsibility. Through our international network in Ukraine, Bulgaria, and Austria, we are able to deliver regenerative treatments that are not only effective but also transparent, reproducible, and aligned with the highest global medical standards.

Individualized Regenerative Therapy: Personalized Preparation, Global Delivery.

Our clinic offers a fully individualized regenerative therapy service, designed specifically for each patient based on their medical history, diagnostic results, and therapeutic goals. Rather than applying standardized protocols, we develop customized cellular and exosome-based bio-products tailored to the patient’s unique biological profile. This personalized approach allows us to optimize the therapeutic composition, concentration, and functional properties of the treatment, ensuring maximum biological relevance and clinical effectiveness.

Once the individualized therapy has been prepared in our certified laboratory, we provide secure worldwide shipment to accredited medical institutions in any country. Delivery is conducted under strictly controlled conditions to preserve the integrity, viability, and biological activity of the therapeutic product. We utilize specialized medical-grade transport systems equipped with continuous temperature monitoring, ensuring that the product remains within the required thermal range throughout the entire journey — from our laboratory to the point of administration.

Our logistics protocol includes real-time tracking, documented chain of custody, and validated cold-chain transport solutions that meet international biomedical shipping standards. Every shipment is accompanied by detailed technical documentation, including product specifications, handling instructions, and administration guidelines. In addition, we maintain direct communication with the receiving medical facility to coordinate delivery timing and ensure readiness for immediate and proper use.

Beyond transportation, our responsibility extends to the clinical application of the therapy. We provide comprehensive remote or on-site support to the receiving medical team, including professional training on correct handling, preparation, and administration of the individualized product. Our specialists offer step-by-step guidance to ensure that all procedures are performed in accordance with our clinical standards and safety protocols.

Throughout the treatment process, we maintain ongoing monitoring and collaboration with the local medical institution. This includes post-administration follow-up, patient progress assessment, and data collection to evaluate therapeutic outcomes. If necessary, our medical experts remain available for consultation, troubleshooting, and protocol adjustments.

By integrating personalized product development, secure global delivery, stringent temperature control, professional training, and continuous medical supervision, we provide a fully controlled and reliable individualized regenerative therapy service that can be implemented safely and effectively anywhere in the world.